Gts Securities »

Theravance Biopharma shares owned by Gts Securities

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Gts Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $430k 25k 17.00

More positions owned by Gts Securities

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Spdr Series Trust St Str Sp Home (XHB)
Microsoft Corporation (MSFT)
Vaneck Etf Trust Gold Miners Etf (GDX)
Amazon (AMZN)
Micron Technology (MU)
Meta Platforms Cl A (META)
Netflix (NFLX)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Gts Securities

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors

View all funds holding Theravance Biopharma